A total of 116 adults with baseline non-high-density lipoprotein cholesterol ( non-HDL-C ) levels of approximately 208mg/dL and low-density lipoprotein cholesterol ( LDL-C ) levels of approximately 175mg/dL were randomized to either placebo or XZK 1200 or 2400mg daily and treated for 12weeks .